EVOFEM BIOSCIENCES, INC.

(EVFM)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
0.9100 USD   -19.47%
07/01U.S. abortion ruling ignites retail interest in women contraceptive makers - Vanda
RE
06/30Evofem Biosciences Receives New US Patent for Contraceptive Gel
MT
06/30Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Rebound In Final Hour of Friday Trade

05/20/2022 | 04:07pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
COVETRUS, INC. 0.48% 20.85 Delayed Quote.4.41%
EVOFEM BIOSCIENCES, INC. -19.47% 0.91 Delayed Quote.-83.84%
FOGHORN THERAPEUTICS INC. 2.79% 13.98 Delayed Quote.-38.87%
NASDAQ COMPOSITE 0.90% 11127.85 Real-time Quote.-28.87%
NOVAVAX, INC. 11.12% 57.15 Delayed Quote.-60.05%
ZR (ZR) - CBE (ELECTRONIC)/C1 -1.86% 16.12 End-of-day quote.12.27%
All news about EVOFEM BIOSCIENCES, INC.
07/01U.S. abortion ruling ignites retail interest in women contraceptive makers - Vanda
RE
06/30Evofem Biosciences Receives New US Patent for Contraceptive Gel
MT
06/30Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent ..
PR
06/30Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent ..
CI
06/28SECTOR UPDATE : Health Care Stocks Decline Tuesday but Largely Outperform Most Other Secto..
MT
06/28SECTOR UPDATE : Health Care Stocks Lower in Afternoon Trade
MT
06/28Wall Street Set to Open Higher
MT
06/28US Stock Futures Move Higher in Premarket Session
MT
06/28Top Premarket Gainers
MT
06/28Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. ..
PR
More news
Analyst Recommendations on EVOFEM BIOSCIENCES, INC.
More recommendations
Financials (USD)
Sales 2022 31,3 M - -
Net income 2022 -109 M - -
Net cash 2022 17,9 M - -
P/E ratio 2022 -0,19x
Yield 2022 -
Capitalization 34,0 M 34,0 M -
EV / Sales 2022 0,51x
EV / Sales 2023 -1,23x
Nbr of Employees 119
Free-Float 97,4%
Chart EVOFEM BIOSCIENCES, INC.
Duration : Period :
Evofem Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOFEM BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 0,91 $
Average target price 8,10 $
Spread / Average Target 790%
EPS Revisions
Managers and Directors
Saundra L. Pelletier Chairman, President & Chief Executive Officer
Justin J. File Chief Financial Officer
Brandi Howard Head-Medical Affairs
Bret Henning Senior Director-Information Technology
Jessie Degarmo Office Administrator
Sector and Competitors
1st jan.Capi. (M$)
EVOFEM BIOSCIENCES, INC.-83.84%34
JOHNSON & JOHNSON3.76%472 389
PFIZER, INC.-11.21%293 506
ELI LILLY AND COMPANY17.38%292 291
ROCHE HOLDING AG-15.48%272 104
ABBVIE INC.13.59%271 782